Aptahem drug candidates

Aptahem develop drug candidates for treating and preventing diseases caused by blockage of blood vessels such as deep vein thrombosis, stroke, or heart failure.

Aptahem drug candidates

Aptahem develop drug candidates for treating and preventing diseases caused by blockage of blood vessels such as deep vein thrombosis, stroke, or heart failure.

Welcome to Aptahem

Aptahem is developing a new class of antithrombotic drugs that, in preclinical studies, show no increased risk of haemorrhage

Business idea

Aptahem intends to commercialize a new group of antithrombotic drugs for the treatment and prevention of diseases caused by blockages to blood vessels, such as heart attack or stroke

Projects

Aptahem is developing antithrombotic drugs based on a completely new technology.

Investor Relations

The lead drug candidate Apta-1 is expected to become an effective and safe treatment

Market

The market for anticoagulants is expected to reach 18.3 billion USD a year by 2020

News

Do you want to meet us?